三福生医

Sunfu Biomedical is a Taiwan-based biotechnology company and a subsidiary of the San Fu Chemical Group, specializing in the development of pharmaceuticals and high-end nutraceuticals. The company focuses on unmet medical needs in oncology and metabolic health, utilizing a combination of chemical synthesis and natural product extraction technologies. Its lead drug candidate, SBD-01, is a botanical-derived therapeutic currently in clinical trials for the treatment of oral cancer. Sunfu also maintains a robust commercial portfolio of functional food ingredients and health supplements marketed under various brands. The company leverages the industrial chemical expertise of its parent company to ensure high standards in manufacturing and quality control.